Product Information
FT MUCUS RELIEF D ER 600-60 MG is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.3841 per EA under NDC 70677126301. Its NADAC has been published 66 times since Jul 2, 2025.
FDA first approved this application on Apr 28, 2020.
Strength
600; 60 mg/1; mg/1
Manufacturer
Strategic Sourcing Services LLCNDC
70677126301
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA212542FDA Approved
4/28/2020
On Market Since
12/13/2024
Pharmacological Classes
Price Statistics
The NADAC for FT MUCUS RELIEF D ER 600-60 MG has been published 66 times since Jul 2, 2025, and over the history we have for it it has risen 45.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3841 per EA |
|---|---|
| All-time high | $0.3891 (Aug 12, 2026) |
| All-time low | $0.2640 (Jul 2, 2025) |
| 52-week high | $0.3891 |
| 52-week low | $0.3056 |
| Median price | $0.3162 |
| Average price | $0.3305 |
| Largest weekly change | +7.7% (Jul 23, 2025) |
| Weeks tracked | 66 |
| Tracking since | Jul 2, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Guaifenesin and Pseudoephedrine HCl market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strategic Sourcing Services LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Guaifenesin and Pseudoephedrine HCl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FT MUCUS RELIEF D ER 600-60 MG?
The current National Average Drug Acquisition Cost (NADAC) for FT MUCUS RELIEF D ER 600-60 MG, manufactured by Strategic Sourcing Services LLC, is $0.3841 per EA (NDC 70677126301), effective Sep 30, 2026.
How has the price of FT MUCUS RELIEF D ER 600-60 MG changed over time?
Over the history we have for it, the NADAC for FT MUCUS RELIEF D ER 600-60 MG has risen 45.5%. It has been tracked across 66 weekly CMS publications since Jul 2, 2025.
What are the highest and lowest recorded NADAC prices for FT MUCUS RELIEF D ER 600-60 MG?
Since Jul 2, 2025, the NADAC for FT MUCUS RELIEF D ER 600-60 MG has ranged from a low of $0.2640 (Jul 2, 2025) to a high of $0.3891 (Aug 12, 2026), with a median of $0.3162 per EA.
Are there cheaper alternatives to FT MUCUS RELIEF D ER 600-60 MG?
No other NADAC-published product currently shares the active ingredient and strength of FT MUCUS RELIEF D ER 600-60 MG in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FT MUCUS RELIEF D ER 600-60 MG?
FT MUCUS RELIEF D ER 600-60 MG (NDC 70677126301) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.